Which has stronger valuation & earnings, GH or NTRA?

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 21.58 -$416.28M -$3.39 N/A Natera $2.31B 17.00 -$208.16M -$1.63 N/A

Is GH or NTRA more profitable?

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Guardant Health -40.10% N/A -26.42% Natera -9.05% -14.74% -10.27%

Does the media favor GH or NTRA?

In the previous week, Guardant Health had 5 more articles in the media than Natera. MarketBeat recorded 16 mentions for Guardant Health and 11 mentions for Natera. Guardant Health's average media sentiment score of 1.15 beat Natera's score of 0.77 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 7 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Natera 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BTSG or NTRA?

In the previous week, BrightSpring Health Services had 6 more articles in the media than Natera. MarketBeat recorded 17 mentions for BrightSpring Health Services and 11 mentions for Natera. Natera's average media sentiment score of 0.77 beat BrightSpring Health Services' score of 0.19 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Natera 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer FMS or NTRA?

In the previous week, Natera had 7 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 11 mentions for Natera and 4 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.30 beat Natera's score of 0.77 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Natera 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, HIMS or NTRA?

Hims & Hers Health has higher revenue and earnings than Natera. Hims & Hers Health is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hims & Hers Health $2.35B 3.39 $128.37M -$0.09 N/A Natera $2.31B 17.00 -$208.16M -$1.63 N/A

Is HIMS or NTRA more profitable?

Hims & Hers Health has a net margin of -0.56% compared to Natera's net margin of -9.05%. Hims & Hers Health's return on equity of 6.10% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Hims & Hers Health -0.56% 6.10% 1.52% Natera -9.05% -14.74% -10.27%

Does the media prefer HIMS or NTRA?

In the previous week, Hims & Hers Health had 2 more articles in the media than Natera. MarketBeat recorded 13 mentions for Hims & Hers Health and 11 mentions for Natera. Natera's average media sentiment score of 0.77 beat Hims & Hers Health's score of 0.63 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Natera 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, PACS or NTRA?

PACS Group has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.29B 1.30 $191.54M $1.56 27.82 Natera $2.31B 17.00 -$208.16M -$1.63 N/A

Is PACS or NTRA more profitable?

PACS Group has a net margin of 4.49% compared to Natera's net margin of -9.05%. PACS Group's return on equity of 26.47% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets PACS Group 4.49% 26.47% 4.36% Natera -9.05% -14.74% -10.27%

Does the media prefer PACS or NTRA?

In the previous week, PACS Group had 2 more articles in the media than Natera. MarketBeat recorded 13 mentions for PACS Group and 11 mentions for Natera. Natera's average media sentiment score of 0.77 beat PACS Group's score of 0.07 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 3 Very Positive mention(s) 7 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Natera 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Natera (NTRA) Competitors

$275.10 +2.22 (+0.81%)

As of 09:59 AM Eastern

Compare

NTRA vs. GH, BTSG, FMS, HIMS, and PACS

Should you buy Natera stock or one of its competitors? MarketBeat compares Natera with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Natera include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Natera compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Comparatively, 5.1% of Natera shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	21.58	-$416.28M	-$3.39	N/A
Natera	$2.31B	17.00	-$208.16M	-$1.63	N/A

Guardant Health has a beta of 1.59, suggesting that its share price is 59% more volatile than the broader market. Comparatively, Natera has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market.

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Natera	-9.05%	-14.74%	-10.27%

In the previous week, Guardant Health had 5 more articles in the media than Natera. MarketBeat recorded 16 mentions for Guardant Health and 11 mentions for Natera. Guardant Health's average media sentiment score of 1.15 beat Natera's score of 0.77 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	7 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Natera	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Guardant Health presently has a consensus price target of $158.74, suggesting a potential downside of 0.67%. Natera has a consensus price target of $267.83, suggesting a potential downside of 2.19%. Given Guardant Health's stronger consensus rating and higher possible upside, research analysts plainly believe Guardant Health is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.86

Summary

Guardant Health beats Natera on 10 of the 17 factors compared between the two stocks.

How does Natera compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment.

In the previous week, BrightSpring Health Services had 6 more articles in the media than Natera. MarketBeat recorded 17 mentions for BrightSpring Health Services and 11 mentions for Natera. Natera's average media sentiment score of 0.77 beat BrightSpring Health Services' score of 0.19 indicating that Natera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	4 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Natera	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BrightSpring Health Services has a net margin of 2.27% compared to Natera's net margin of -9.05%. BrightSpring Health Services' return on equity of 14.63% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Natera	-9.05%	-14.74%	-10.27%

BrightSpring Health Services has a beta of 1.79, suggesting that its stock price is 79% more volatile than the broader market. Comparatively, Natera has a beta of 1.51, suggesting that its stock price is 51% more volatile than the broader market.

BrightSpring Health Services presently has a consensus target price of $70.12, suggesting a potential downside of 0.61%. Natera has a consensus target price of $267.83, suggesting a potential downside of 2.19%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, equities research analysts clearly believe BrightSpring Health Services is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	1 Hold rating(s)	18 Buy rating(s)	1 Strong Buy rating(s)	3.00
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.86

99.9% of Natera shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by insiders. Comparatively, 5.1% of Natera shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

BrightSpring Health Services has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	1.08	$190.67M	$1.41	50.04
Natera	$2.31B	17.00	-$208.16M	-$1.63	N/A

Summary

BrightSpring Health Services beats Natera on 12 of the 17 factors compared between the two stocks.

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, media sentiment and institutional ownership.

Fresenius Medical Care AG & Co. KGaA presently has a consensus target price of $28.00, indicating a potential upside of 15.46%. Natera has a consensus target price of $267.83, indicating a potential downside of 2.19%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.86

Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, Natera has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market.

In the previous week, Natera had 7 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 11 mentions for Natera and 4 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.30 beat Natera's score of 0.77 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Natera	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Natera's net margin of -9.05%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
Natera	-9.05%	-14.74%	-10.27%

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 5.1% of Natera shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.59	$1.11B	$1.90	12.76
Natera	$2.31B	17.00	-$208.16M	-$1.63	N/A

Summary

Fresenius Medical Care AG & Co. KGaA beats Natera on 9 of the 17 factors compared between the two stocks.

How does Natera compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Natera (NASDAQ:NTRA) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

In the previous week, Hims & Hers Health had 2 more articles in the media than Natera. MarketBeat recorded 13 mentions for Hims & Hers Health and 11 mentions for Natera. Natera's average media sentiment score of 0.77 beat Hims & Hers Health's score of 0.63 indicating that Natera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Natera	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 5.1% of Natera shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Hims & Hers Health currently has a consensus price target of $30.70, suggesting a potential downside of 10.70%. Natera has a consensus price target of $267.83, suggesting a potential downside of 2.19%. Given Natera's stronger consensus rating and higher possible upside, analysts plainly believe Natera is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.86

Hims & Hers Health has higher revenue and earnings than Natera. Hims & Hers Health is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.39	$128.37M	-$0.09	N/A
Natera	$2.31B	17.00	-$208.16M	-$1.63	N/A

Hims & Hers Health has a net margin of -0.56% compared to Natera's net margin of -9.05%. Hims & Hers Health's return on equity of 6.10% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Natera	-9.05%	-14.74%	-10.27%

Hims & Hers Health has a beta of 2.35, meaning that its share price is 135% more volatile than the broader market. Comparatively, Natera has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market.

Summary

Hims & Hers Health beats Natera on 9 of the 17 factors compared between the two stocks.

How does Natera compare to PACS Group?

PACS Group (NYSE:PACS) and Natera (NASDAQ:NTRA) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

In the previous week, PACS Group had 2 more articles in the media than Natera. MarketBeat recorded 13 mentions for PACS Group and 11 mentions for Natera. Natera's average media sentiment score of 0.77 beat PACS Group's score of 0.07 indicating that Natera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	3 Very Positive mention(s)	7 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Natera	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PACS Group has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.30	$191.54M	$1.56	27.82
Natera	$2.31B	17.00	-$208.16M	-$1.63	N/A

PACS Group has a net margin of 4.49% compared to Natera's net margin of -9.05%. PACS Group's return on equity of 26.47% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Natera	-9.05%	-14.74%	-10.27%

99.9% of Natera shares are held by institutional investors. 70.1% of PACS Group shares are held by insiders. Comparatively, 5.1% of Natera shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

PACS Group has a beta of -0.08, indicating that its share price is 108% less volatile than the broader market. Comparatively, Natera has a beta of 1.51, indicating that its share price is 51% more volatile than the broader market.

PACS Group presently has a consensus price target of $50.60, suggesting a potential upside of 16.59%. Natera has a consensus price target of $267.83, suggesting a potential downside of 2.19%. Given PACS Group's higher probable upside, equities research analysts clearly believe PACS Group is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.86

Summary

PACS Group beats Natera on 10 of the 17 factors compared between the two stocks.

Get Natera News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NTRA vs. The Competition

Export

Metric	Natera	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$39.51B	$9.60B	$7.05B	$12.61B
Dividend Yield	N/A	1.62%	2.68%	8.00%
P/E Ratio	-169.25	26.00	27.10	24.26
Price / Sales	17.00	17.40	588.85	117.88
Price / Cash	N/A	14.81	29.22	49.36
Price / Book	22.12	6.05	10.85	6.29
Net Income	-$208.16M	$177.20M	$3.58B	$330.66M
7 Day Performance	-2.65%	-2.07%	-2.12%	-1.35%
1 Month Performance	29.12%	6.96%	3.27%	-0.64%
1 Year Performance	73.11%	11.42%	26.33%	19.08%

Natera Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NTRA Natera	2.2085 of 5 stars	$275.02 +0.8%	$267.83 -2.6%	+70.1%	$39.35B	$2.31B	N/A	6,140	Analyst Forecast
GH Guardant Health	2.8167 of 5 stars	$168.82 +0.5%	$150.91 -10.6%	+215.2%	$22.27B	$982.02M	N/A	2,506	News Coverage Positive News Analyst Forecast
BTSG BrightSpring Health Services	2.5777 of 5 stars	$70.56 +2.2%	$63.67 -9.8%	+242.9%	$13.62B	$12.91B	55.67	23,500	Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.2093 of 5 stars	$23.62 +0.4%	$28.00 +18.5%	-9.6%	$12.64B	$22.20B	12.43	1,488	Positive News Gap Up
HIMS Hims & Hers Health	3.2282 of 5 stars	$38.34 +4.2%	$30.63 -20.1%	-28.2%	$8.52B	$2.35B	N/A	2,442

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NTRA) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Natera (NTRA) Competitors

NTRA vs. GH, BTSG, FMS, HIMS, and PACS

How does Natera compare to Guardant Health?

Summary

How does Natera compare to BrightSpring Health Services?

Summary

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Natera compare to Hims & Hers Health?

Summary

How does Natera compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRA vs. The Competition

Natera Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Natera (NTRA) Competitors

NTRA vs. GH, BTSG, FMS, HIMS, and PACS

How does Natera compare to Guardant Health?

Do institutionals and insiders have more ownership in GH or NTRA?

Which has stronger valuation & earnings, GH or NTRA?

Which has more risk and volatility, GH or NTRA?

Is GH or NTRA more profitable?

Does the media favor GH or NTRA?

Do analysts recommend GH or NTRA?

Summary

How does Natera compare to BrightSpring Health Services?

Does the media prefer BTSG or NTRA?

Is BTSG or NTRA more profitable?

Which has more risk & volatility, BTSG or NTRA?

Do analysts rate BTSG or NTRA?

Do insiders and institutionals hold more shares of BTSG or NTRA?

Which has stronger valuation and earnings, BTSG or NTRA?

Summary

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Do analysts rate FMS or NTRA?

Which has more volatility and risk, FMS or NTRA?

Does the media prefer FMS or NTRA?

Is FMS or NTRA more profitable?

Do insiders and institutionals believe in FMS or NTRA?

Which has preferable earnings & valuation, FMS or NTRA?

Summary

How does Natera compare to Hims & Hers Health?

Does the media prefer HIMS or NTRA?

Do insiders and institutionals have more ownership in HIMS or NTRA?

Do analysts prefer HIMS or NTRA?

Which has better earnings and valuation, HIMS or NTRA?

Is HIMS or NTRA more profitable?

Which has more volatility & risk, HIMS or NTRA?

Summary

How does Natera compare to PACS Group?

Does the media prefer PACS or NTRA?

Which has higher earnings and valuation, PACS or NTRA?

Is PACS or NTRA more profitable?

Do institutionals and insiders have more ownership in PACS or NTRA?

Which has more risk and volatility, PACS or NTRA?

Do analysts recommend PACS or NTRA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRA vs. The Competition

Natera Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools